• EN

Scientific Paper Award 2013



Scientific Paper Award 2013: winning and shortlisted articles

Basic biological, neurobiological and behavioural research shortlist

  1. Sophia Schneider, Jan Peters, Uli Bromberg, Stefanie Brassen, Stephan F. Miedl, Tobias Banaschewski, Gareth J. Barker, Patricia Conrod, Herta Flor, Hugh Garavan, Andreas Heinz, Bernd Ittermann, Mark Lathrop, Eva Loth, Karl Mann, Jean-Luc Martinot, Frauke Nees, Tomas Paus, M.D., Marcella Rietschel, Trevor W. Robbins, Michael N. Smolka, Rainer Spanagel, Andreas Ströhle, Maren Struve, Gunter Schumann, Christian Büchel, The IMAGEN Consortium, 'Risk taking and the adolescent reward system : a potential common link to substance abuse' in Am J Psychiatry 2012; 169: 39–46
  2. Tom P. Freeman, Celia J. A. Morgan, James Vaughn-Jones, Nahida Hussain, Kash Karimi & H. Valerie Curran, 'Cognitive and subjective effects of mephedrone and factors influencing use of a ‘new legal high’ in Addiction, 107, 792–800
  3. Maren Hermanns-Clausen, Stefan Kneisel, Bela Szabo & Volker Auwärter, 'Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings' in Addiction, 108, 534–544

Population based and epidemiology research shortlist

  1. Knut Boe Kielland, Kjell Skaug, Ellen J. Amundsen, Olav Dalgard, 'All-cause and liver-related mortality in hepatitis C infected drug users followed for 33 years: A controlled study' in Journal of Hepatology 2013, vol. 58 j 31–37
  2. Malcolm J Reid, Katherine H Langford, Merete Grung, Hallvard Gjerde, Ellen J Amundsen, Jorg Morland, Kevin V Thomas, 'Estimation of cocaine consumption in the community: a critical comparison of the results from three complimentary techniques' in BMJ Open 2012;2:e001637
  3. Wulf Rössler, Michael P. Hengartner, Jules Angst & Vladeta Ajdacic-Gross, 'Linking substance use with symptoms of subclinical psychosis in a community cohort over 30 years' in Addiction, 107, 1174–1184

Demand reduction research shortlist

  1. Dagmar Hedrich, Paula Alves, Michael Farrell, Heino Stöver, Lars Møller & Soraya Mayet, 'The effectiveness of opioid maintenance treatment in prison settings: a systematic review' in Addiction, 107, 501–517
  2. E. Hoch, R. Noack, J. Henker, A. Pixa, M. Höfler, S. Behrendt, G. Bühringer, H.-U. Wittchen, 'Efficacy of a targeted cognitive–behavioral treatment program for cannabis use disorders (CANDIS)' in Eur. Neuropsychopharmacol. (2011)
  3. Peter Vickerman, Natasha Martin, Katy Turner & Matthew Hickman, 'Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settings' in Addiction, 107, 1984–1995

Policy, supply and crime research shortlist

  1. Rudolf Rosenauer, Anton Luf, Marion Holy, Michael Freissmuth, Rainer Schmid, and Harald H. Sitte, 'A combined approach using transporter-flux assays and mass spectrometry to examine psychostimulant street drugs of unknown content' in ACS Chem. Neurosci. 2013, 4, 182−190
  2. Ivana Obradovic, 'La pénalisation de l'usage de stupéfiants en France au miroir des statistiques administratives. Enjeux et controverses' in Déviance et Société 2012, vol. 36, n° 4, pp. 441-469
  3. Bernd Werse & Cornelia Morgenstern, 'How to handle legal highs? Findings from a German online survey and considerations on drug policy issues' in Drugs and Alcohol Today, vol. 12 no. 4 2012, pp. 222-231
  4. Marije Wouters, Annemieke Benschop, Margriet van Laar & Dirk J. Korf, 'Cannabis use and proximity to coffee shops in the Netherlands' in European Journal of Criminology 2012 9: 337


About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Tel. (351) 211 21 02 00

More contact options >>

Page last updated: Thursday, 12 June 2014